Literature DB >> 18074417

Assessment of Crohn's disease activity by doppler ultrasound of superior mesenteric artery and mural arteries in thickened bowel wall: cross-sectional study.

Ivica Sjekavica1, Vinka Barbarić-Babić, Zeljko Krznarić, Melita Molnar, Silvija Cuković-Cavka, Ranka Stern-Padovan.   

Abstract

AIM: To define sensitive and reliable Doppler parameters for measurements in the superior mesenteric artery and mural arteries of affected bowel loops used in the assessment of Crohn disease activity.
METHODS: We performed cross-sectional study at a tertiary care setting in Zagreb, Croatia, between January 2001 and March 2005. We measured arterial flow in the superior mesenteric artery and affected bowel wall in 138 patients with Crohn disease (74 with active, 64 with inactive disease) and 67 healthy volunteers. The disease activity was determined by the clinical examination, Crohn disease activity index, and standard laboratory tests. Superior mesenteric artery color and pulsed Doppler parameters were peak systolic velocity, end-diastolic velocity, resistance index, mean velocity flow, cross-sectional area, and flow volume. When gut mural vessels were identified, we performed spectral analysis of mural arteries by pulsed Doppler, with a measurement of resistance index.
RESULTS: The measurements in the superior mesenteric artery showed statistically and clinically significant difference in flow volume in active group, compared with inactive and control groups (C+/-Q=564+/-263 mL/min for active, 421+/-157 for inactive and 416+/-248 for control group). Affected bowel loops analysis showed significant difference between inactive and active Crohn disease group in wall thickness (3.1+/-1.4 vs 5.0+/-1.8 mm, P<0.001, Mann-Whitney test) while all participants from control group had thickness below 2mm. Intensity of color Doppler signals was different for all groups (P<0.001, chi(2) test) with the highest level of hyperemia in the active group. Resistance index measurements of mural arteries in bowel wall revealed differences between all three groups (0.61+/-0.05 in active group, 0.71+/-0.05 in the inactive group and 0.80+/-0.11 in the control group, P<0.001, Kruskal-Wallis test).
CONCLUSION: Intensity of color Doppler signals and resistance index measurements of mural arteries in the thickened bowel wall can be used as quantitative diagnostic tool in the assessment of Crohn disease activity.

Entities:  

Mesh:

Year:  2007        PMID: 18074417      PMCID: PMC2213815          DOI: 10.3325/cmj.2007.6.822

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  29 in total

1.  Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children.

Authors:  H P Haber; A Busch; R Ziebach; M Stern
Journal:  Lancet       Date:  2000-04-08       Impact factor: 79.321

2.  Development and validation of an ultrasonographic activity index of Crohn's disease.

Authors:  Z Jakab; E Cserepes; Z Tulassay
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-12       Impact factor: 2.566

3.  Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study.

Authors:  M F Byrne; M A Farrell; S Abass; A Fitzgerald; J C Varghese; F Thornton; F E Murray; M J Lee
Journal:  Clin Radiol       Date:  2001-12       Impact factor: 2.350

4.  Activity of Crohn's disease assessed by colour Doppler ultrasound analysis of the affected loops.

Authors:  J M Esteban; L Maldonado; V Sanchiz; M Minguez; A Benages
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

5.  Non-invasive evaluation of activity in inflammatory bowel disease by power Doppler sonography.

Authors:  R Heyne; S Rickes; P Bock; S Schreiber; W Wermke; H Lochs
Journal:  Z Gastroenterol       Date:  2002-03       Impact factor: 2.000

6.  Contrast-enhanced ultrasonography in Crohn's disease.

Authors:  A De Pascale; G Garofalo; M Perna; S Priola; C Fava
Journal:  Radiol Med       Date:  2006-05-25       Impact factor: 3.469

7.  Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity.

Authors:  J Spalinger; H Patriquin; M C Miron; G Marx; D Herzog; J Dubois; M Dubinsky; E G Seidman
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

8.  Ultrasound in Crohn's disease of the small bowel.

Authors:  Z Tarján; G Tóth; T Györke; A Mester; K Karlinger; E K Makó
Journal:  Eur J Radiol       Date:  2000-09       Impact factor: 3.528

Review 9.  Ultrasonography of chronic inflammatory bowel diseases.

Authors:  P J Valette; M Rioux; F Pilleul; J C Saurin; P Fouque; L Henry
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

10.  Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn's disease.

Authors:  Wolfgang Kratzer; Christian von Tirpitz; Richard Mason; Max Reinshagen; Guido Adler; Peter Möller; Andrea Rieber; Volker Kächele
Journal:  J Ultrasound Med       Date:  2002-02       Impact factor: 2.153

View more
  13 in total

1.  Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: a preliminary study.

Authors:  Alex Menys; David Atkinson; Freddy Odille; Asia Ahmed; Marco Novelli; Manuel Rodriguez-Justo; Ian Proctor; Shonit Punwani; Steve Halligan; Stuart A Taylor
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

Review 2.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Resistance index in mural arteries of thickened bowel wall: predictive value for Crohn disease activity assessment in pediatric patients.

Authors:  Ivica Sjekavica; Vinka Barbarić-Babić; Vice Šunjara; Marko Kralik; Irena Senečić-Čala; Margareta Dujšin; Ranka Stern-Padovan
Journal:  Wien Klin Wochenschr       Date:  2013-04-13       Impact factor: 1.704

4.  Ultrasound of the small bowel in Crohn's disease.

Authors:  Emma Calabrese; Francesca Zorzi; Francesco Pallone
Journal:  Int J Inflam       Date:  2012-02-21

5.  Haemodynamic changes in the superior mesenteric artery induced by acupuncture stimulation on the lower limbs.

Authors:  Masashi Watanabe; Shin Takayama; Yoshiko Yamamoto; Satoru Nagase; Takashi Seki; Nobuo Yaegashi
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-23       Impact factor: 2.629

6.  Effectiveness and Power of Abdominal Ultrasonography in the Assessment of Crohn's Disease Activity: Comparison with Clinical, Endoscopic, and CT Enterography Findings.

Authors:  Betül Yiğit; Orhan Sezgin; Elif Yorulmaz; Mehmet Şükrü Ertürk; Umut Erdem; Uğur Yanç; Gamze Bilik Oyman; Hatice Yorulmaz
Journal:  Turk J Gastroenterol       Date:  2022-04       Impact factor: 1.555

7.  Assessment of Crohn's disease activity by Doppler sonography.

Authors:  Ying Na; Jian Zhou; Xiang-Min Xiao; Wen-Xing Zhang; Hong-Lei Gao; Yang Wang; Xiao-Yan Han; Zuo-Cheng Sun; Hui-Min Xu
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

8.  Inflammatory bowel disease and superior mesenteric artery thromboembolism.

Authors:  Steven Nicolaides; Abhinav Vasudevan; Daniel Van Langenberg
Journal:  Intest Res       Date:  2019-09-03

9.  Crohn's disease activity assessed by Doppler sonography: the role of aortic flow parameters.

Authors:  Thais Guaraná Andrade; Homero Soares Fogaça; Celeste Carvalho Siqueira Elia; Melissa Tassano Pitrowsky; Heitor Siffert Pereira de Souza
Journal:  Clinics (Sao Paulo)       Date:  2013-04       Impact factor: 2.365

Review 10.  Transabdominal ultrasonography of the small bowel.

Authors:  Rudolf Kralik; Peter Trnovsky; Marcela Kopáčová
Journal:  Gastroenterol Res Pract       Date:  2013-11-19       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.